TABLE I.
Characteristics of the study cohort
| Characteristic | Value |
|---|---|
| Of the patients (n=24) | |
| Age (years) | |
| Median | 74.5 |
| Range | 70–84 |
| Sex [n (%) men] | 17 (70.8) |
| Marital status [n (%)] | |
| Married | 19 (86.4) |
| Divorced or single | 3 (13.6) |
| Unknown | 2 |
| Have children [n (%)] | 21 (87.5) |
| Living situation [n (%)] | |
| With family | 20 (83.3) |
| Alone | 4 (16.7) |
| Employment [n (%)] | |
| Retired | 19 (90.5) |
| Working | 2 (9.5) |
| Unknown | 3 |
| Mean BMI (kg/m 2) | 25.9±4.4 |
| Unintentional weight loss in preceding 6 months [n (%)] | |
| <5 lbs. | 14 (58.3) |
| 5–10 lbs. | 6 (25) |
| >10 lbs. | 4 (16.7) |
| ECOG PS [n (%)] | |
| 0 | 4 (16.7) |
| 1 | 9 (37.5) |
| 2 | 10 (41.7) |
| 3+ | 1 (4.2) |
| Score on the CCI | |
| Median | 1 |
| Range | 0–4 |
| CCI score groups [n (%)] | |
| 0 | 7 (29.2) |
| 1 | 8 (33.3) |
| 2+ | 9 (37.5) |
| Of the cancer and prior treatments | |
| Tumour type [n (%)] | |
| Colorectal cancer | 6 (25) |
| Non-small-cell lung cancer | 16 (66.7) |
| Small-cell lung cancer | 1 (4.2) |
| Mesothelioma | 1 (4.2) |
| Stage [n (%)] | |
| II | 6 (25) |
| III | 3 (12.5) |
| IV | 15 (62.5) |
| Time since cancer diagnosis (months) | |
| Median | 3.5 |
| Range | 0–65 |
| Prior therapies [n (%)] | |
| Chemotherapy | 7 (29.2) |
| Radiation | 8 (33.3) |
| Resection of primary tumour | 14 (58.3) |
| Lines of prior systemic therapy (n) | |
| Median | 0 |
| Range | 0–5 |
| Prior systemic therapy groups [n (%)] | |
| 0 Lines | 18 (75) |
| 1 Lines | 3 (12.5) |
| 2+ Lines | 3 (12.5) |
| Of current chemotherapy | |
| Agents received [n (%)] | |
| 1 | 4 (16.7) |
| 2+ | 20 (83.3) |
| Initial dose [n (%)] | |
| Standard | 15 (62.5) |
| Dose-reduced | 9 (37.5) |
BMI = body mass index; ECOG PS = Eastern Cooperative Oncology Group performance status; CCI = Charlson comorbidity index.